STYLE SHEET
GLOBAL CSS
COLORS
ANIMATIONS
MEDIA QUERY
SPACING SYSTEM

Why only for healthcare professionals?

The content on these information pages is directed solely at you if you are a doctor, nurse, or pharmacist, as it concerns treatment with prescription medicines.

Please confirm that you are a healthcare professional (healthcare assistant, nurse, doctor, psychologist, or other licensed healthcare professional).

Back to main page

Confirm and continue

News
August 22, 2025

Mail Online: Gemma Collins about her weight loss journey with Yazen

Gemma Collins reveals her weight loss journey with Yazen’s weight-loss programme, sharing how it has transformed her health and happiness.

Gemma Collins opens up about her life-changing weight loss journey with Yazen

TV personality Gemma Collins has revealed her transformative experience with Yazen's weight-loss programme prescribed through Yazen, a brand she now partners with. Sharing her progress on social media, the former TOWIE star disclosed that she has already dropped two dress sizes, calling the treatment "life-changing."

After struggling with weight-related challenges for years, Gemma expressed feeling liberated and healthier. She emotionally shared how the injections have lifted a “massive weight off her shoulders” after enduring bullying over her size throughout her life.

In a heartfelt video, Gemma encouraged her followers to explore the treatment, emphasising that her journey is about feeling healthier, happier, and finally free to live her best life. She also reflected on her desire to be a more active, energetic mother in the future, addressing past fertility struggles.

Read the full article on Mail Online.

More news

Yazen achieved record-breaking growth in 2025, doubling its revenue.

In 2025, Yazen's revenue surged 87% to nearly €29.4 million, with gross profits doubling to €16.5 million. Now treating over 37,000 active patients across seven countries, the company is eyeing further expansion into two more markets in 2026. Despite an EBITDA of –€5.7 million due to heavy growth investment, Yazen remains a leader in European obesity care.

Yazen presents new data on digital obesity care at NOM 2026

Yazen presents an oral scientific abstract at the Nordic Obesity Meeting (NOM26), highlighting high-volume patient–caregiver interactions in a fully digital obesity care model.

Yazen Highly Commended in the HTN Now 2025/26 Awards

Yazen’s work powering digital patient transformation for sustainable weight care is recognised by the HTN Now 2025/26 Awards in the category of Digital Patient Transformation.